Terms: = Ovarian cancer AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037 AND Staging
144 results:
1. Oncologic outcomes of robot-assisted laparoscopy versus conventional laparoscopy for the treatment of apparent early-stage endometrioid adenocarcinoma of the uterus.
Lim YH; Dagher C; Abu-Rustum NR; Mueller JJ; Sonoda Y; Zivanovic O; Broach V; Leitao MM
Gynecol Oncol; 2023 Dec; 179():152-157. PubMed ID: 37980770
[TBL] [Abstract] [Full Text] [Related]
2. Mapping sentinel lymph nodes in early-stage ovarian cancer (MELISA) trial - a further step towards lymphadenectomy replacement.
Agustí N; Vidal-Sicart S; Paredes P; Celada-Castro C; Migliorelli F; Glickman A; Marina T; Fusté P; Carreras-Dieguez N; Saco A; Díaz-Feijóo B; Torné A
Gynecol Oncol; 2023 Dec; 179():145-151. PubMed ID: 37980769
[TBL] [Abstract] [Full Text] [Related]
3. Lymph node staging in grade 1-2 endometrioid ovarian carcinoma apparently confined to the ovary: Is it worth?
Bizzarri N; Imterat M; Fruscio R; Giannarelli D; Perrone AM; Mancari R; Traut A; Rosati A; du Bois A; Ferrari D; De Iaco P; Ergasti R; Ataseven B; Bianchi T; Di Stanislao M; Perri MT; Heitz F; Concin N; Fanfani F; Vizza E; Scambia G; Harter P; Fagotti A
Eur J Cancer; 2023 Dec; 195():113398. PubMed ID: 37890354
[TBL] [Abstract] [Full Text] [Related]
4. The OCDA-Net: a 3D convolutional neural network-based system for classification and staging of ovarian cancer patients using [
Sadeghi MH; Sina S; Alavi M; Giammarile F
Ann Nucl Med; 2023 Dec; 37(12):645-654. PubMed ID: 37768493
[TBL] [Abstract] [Full Text] [Related]
5. Recurrence Risk Stratification for Women With FIGO Stage I Uterine Endometrioid Carcinoma Who Underwent Surgical Lymph Node Evaluation.
Ghanem AI; Bhatnagar A; Elshaikh M; Hijaz M; Elshaikh MA
Am J Clin Oncol; 2023 Dec; 46(12):537-542. PubMed ID: 37679878
[TBL] [Abstract] [Full Text] [Related]
6. The impact of lymphovascular space invasion on survival in early stage low-grade endometrioid endometrial cancer.
Yarandi F; Shirali E; Akhavan S; Nili F; Ramhormozian S
Eur J Med Res; 2023 Mar; 28(1):118. PubMed ID: 36915143
[TBL] [Abstract] [Full Text] [Related]
7. Management of Borderline ovarian tumors (BOT): results of a retrospective, single center study in Switzerland.
Kipp B; Vidal A; Lenick D; Christmann-Schmid C
J Ovarian Res; 2023 Jan; 16(1):20. PubMed ID: 36691070
[TBL] [Abstract] [Full Text] [Related]
8. Assessment of galectins -1, -3, -4, -8, and -9 expression in ovarian carcinoma patients with clinical implications.
Mohamed RM; Emam A; Abdelfattah MM; Abdel-Mageed AI; Abdelhafeez MA; Helwa R
World J Surg Oncol; 2022 Sep; 20(1):276. PubMed ID: 36050693
[TBL] [Abstract] [Full Text] [Related]
9. Effect of Hospital Case-Volume on Mortality after ovarian cancer Surgery: A Population-Based Retrospective Cohort Study.
Kim BR; Kim H; Joo SG; Jang EJ; Jo J; Lee H; Ryu HG
Gynecol Obstet Invest; 2022; 87(6):364-372. PubMed ID: 36044873
[TBL] [Abstract] [Full Text] [Related]
10. Embryonal Rhabdomyosarcoma of the Uterine Cervix: A Clinicopathologic Study of 94 Cases Emphasizing Issues in Differential Diagnosis staging, and Prognostic Factors.
Devins KM; Young RH; Ghioni M; Burandt E; Bennett JA; Oliva E
Am J Surg Pathol; 2022 Nov; 46(11):1477-1489. PubMed ID: 35941719
[TBL] [Abstract] [Full Text] [Related]
11. Increased survival in non-endometrioid endometrial cancer after introducing lymphadenectomy and tailoring radiotherapy - A population-based cohort study.
Åkesson Å; Adok C; Dahm-Kähler P
Eur J Cancer; 2022 Jul; 169():54-63. PubMed ID: 35500461
[TBL] [Abstract] [Full Text] [Related]
12. Clinical and pathological patterns of non-epithelial malignant ovarian tumours in Western Saudi Arabia.
Anfinan NM; Shaldoom ES; Sait H; Baghlaf O; Alwazzan A; Mousa A; Sait M; Alkhalili B; Sait K
Niger Postgrad Med J; 2022; 29(2):116-122. PubMed ID: 35488579
[TBL] [Abstract] [Full Text] [Related]
13. Overview of adjuvant radiotherapy on survival, failure pattern and toxicity in stage I to II endometrial carcinoma: a long-term multi-institutional analysis in China.
Wang W; Wang T; Liu Z; He J; Sun X; Zhong W; Zhao F; Li X; Li S; Zhu H; Ma Z; Hu K; Zhang F; Hou X; Wei L; Zou L
BMC Cancer; 2022 Mar; 22(1):266. PubMed ID: 35287626
[TBL] [Abstract] [Full Text] [Related]
14. Surgical management and outcomes for stage 1 malignant ovarian germ cell tumours: A UK multicentre retrospective cohort study.
Graham R; MacDonald ND; Lockley M; Miller R; Butler J; Murali K; Sarker SJ; Banerjee S; Stoneham S; Shamash J; Liberale V; Berney DM; Newton C
Eur J Obstet Gynecol Reprod Biol; 2022 Apr; 271():138-144. PubMed ID: 35192975
[TBL] [Abstract] [Full Text] [Related]
15. Multi-Institutional Review of the Preoperative Diagnostic Accuracy for Pediatric ovarian Mature Cystic Teratomas.
Knaus ME; Onwuka AJ; Afrazi A; Breech L; Corkum KS; Dillon PA; Ehrlich PF; Fallat ME; Fraser JD; Gadepalli SK; Grabowski JE; Hertweck SP; Kabre R; Lal DR; Landman MP; Lawrence AE; Leys CM; Mak GZ; Markel TA; Merchan N; Overman RE; Rademacher BL; Raiji MT; Rymeski B; Sato TT; Scannel M; Schikler AG; Sujka JA; Wright T; Aldrink JH; Hewitt GD; Minneci PC; Deans KJ;
J Pediatr Adolesc Gynecol; 2022 Aug; 35(4):478-485. PubMed ID: 35124214
[TBL] [Abstract] [Full Text] [Related]
16. A retrospective study evaluating the impact of scattering radiation from imaging procedures on oocyte quality during ovarian stimulation for fertility preservation in young breast cancer patients.
Condorelli M; Sens M; Goldrat O; Delbaere A; Racapé J; Lambertini M; Demeestere I
Breast Cancer Res Treat; 2022 Feb; 192(1):123-130. PubMed ID: 35039953
[TBL] [Abstract] [Full Text] [Related]
17. Preoperative magnetic resonance imaging predicts clinicopathological parameters and stages of endometrial carcinomas.
Wu CY; Tai YJ; Shih IL; Chiang YC; Chen YL; Hsu HC; Cheng WF
Cancer Med; 2022 Feb; 11(4):993-1004. PubMed ID: 34967506
[TBL] [Abstract] [Full Text] [Related]
18. Regorafenib or Tamoxifen for platinum-sensitive recurrent ovarian cancer with rising CA125 and no evidence of clinical or RECIST progression: A GINECO randomized phase II trial (REGOVAR).
Trédan O; Provansal M; Abdeddaim C; Lardy-Cleaud A; Hardy-Bessard AC; Kalbacher E; Floquet A; Venat-Bouvet L; Lortholary A; Pop O; Frenel JS; Cancel M; Largillier R; Louvet C; You B; Zannetti A; Anota A; Treilleux I; Pissaloux D; Houlier A; Savoye AM; Mouret-Reynier MA; Meunier J; Levaché CB; Brocard F; Ray-Coquard I
Gynecol Oncol; 2022 Jan; 164(1):18-26. PubMed ID: 34696892
[TBL] [Abstract] [Full Text] [Related]
19. Laparoscopic management of advanced epithelial ovarian cancer after neoadjuvant chemotherapy: a phase II prospective multicenter non-randomized trial (the CILOVE study).
Pomel C; Akladios C; Lambaudie E; Rouzier R; Ferron G; Lecuru F; Classe JM; Fourchotte V; Paillocher N; Wattiez A; Montoriol PF; Thivat E; Beguinot M; Canis M
Int J Gynecol Cancer; 2021 Dec; 31(12):1572-1578. PubMed ID: 34670829
[TBL] [Abstract] [Full Text] [Related]
20. Clinical outcomes of patients with endometrioid epithelial ovarian cancer following surgical treatment.
Cybulska P; Tseng J; Zhou QC; Iasonos A; Delair DF; Mueller JJ; Long Roche KC; Abu-Rustum NR; Leitao MM
J Surg Oncol; 2021 Oct; 124(5):846-851. PubMed ID: 34270102
[TBL] [Abstract] [Full Text] [Related]
[Next]
